Cargando…

Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression

α-Dystroglycanopathy (α-DGP) is a group of muscular dystrophy characterized by abnormal glycosylation of α-dystroglycan (α-DG), including Fukuyama congenital muscular dystrophy (FCMD), muscle-eye-brain disease, Walker-Warburg syndrome, and congenital muscular dystrophy type 1D (MDC1D), etc. LARGE, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohtsuka, Yoshihisa, Kanagawa, Motoi, Yu, Chih-Chieh, Ito, Chiyomi, Chiyo, Tomoko, Kobayashi, Kazuhiro, Okada, Takashi, Takeda, Shin'ichi, Toda, Tatsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321163/ https://www.ncbi.nlm.nih.gov/pubmed/25661440 http://dx.doi.org/10.1038/srep08316

Ejemplares similares

Elimination of fukutin reveals cellular and molecular pathomechanisms in muscular dystrophy-associated heart failure
por: Ujihara, Yoshihiro, et al.
Publicado: (2019)

Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy
por: Kuwabara, Naoyuki, et al.
Publicado: (2020)

Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy
por: Kanagawa, Motoi, et al.
Publicado: (2014)

Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017)

Fukutin regulates tau phosphorylation and synaptic function: Novel properties of fukutin in neurons
por: Tsukui, Ryota, et al.
Publicado: (2022)

Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
por: Taniguchi-Ikeda, Mariko, et al.
Publicado: (2011)

Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage
por: Sudo, Atsushi, et al.
Publicado: (2018)

Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan
por: Kuraoka, Mutsuki, et al.
Publicado: (2021)

Extensive but Coordinated Reorganization of the Membrane Skeleton in Myofibers of Dystrophic (mdx) Mice
por: Williams, McRae W., et al.
Publicado: (1999)

CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model
por: Tokuoka, Hideki, et al.
Publicado: (2022)

Roles of Fukutin, the Gene Responsible for Fukuyama-Type Congenital Muscular Dystrophy, in Neurons: Possible Involvement in Synaptic Function and Neuronal Migration
por: Hiroi, Atsuko, et al.
Publicado: (2011)

Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset
por: Smogavec, Mateja, et al.
Publicado: (2017)

Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects
por: Banks, Glen B., et al.
Publicado: (2020)

Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy
por: Foltz, Steven J., et al.
Publicado: (2016)

Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment
por: Hayashita-Kinoh, Hiromi, et al.
Publicado: (2020)

Congenital hearing impairment associated with peripheral cochlear nerve dysmyelination in glycosylation-deficient muscular dystrophy
por: Morioka, Shigefumi, et al.
Publicado: (2020)

Expression and purification of the transmembrane domain of Fukutin-I for biophysical studies
por: Marius, P., et al.
Publicado: (2010)

Probing the oligomeric state and interaction surfaces of Fukutin-I in dilauroylphosphatidylcholine bilayers
por: Marius, P., et al.
Publicado: (2011)

Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
por: Lin, Yung-Yao, et al.
Publicado: (2011)

Efficacy and muscle safety assessment of fukutin-related protein gene therapy
por: Benasutti, Halli, et al.
Publicado: (2023)

ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy
por: Bround, Michael J., et al.
Publicado: (2023)

In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson’s disease
por: Uenaka, Takeshi, et al.
Publicado: (2018)

Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein
por: Seki, Tsuneyoshi, et al.
Publicado: (2020)

Inflammatory predisposition predicts disease phenotypes in muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2016)

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
por: Okada, Takashi, et al.
Publicado: (2013)

Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient
por: Saito, Takashi, et al.
Publicado: (2010)

Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy
por: Burr, A R, et al.
Publicado: (2015)

Dystrophic muscle distribution in late-stage muscular dystrophy
por: Pilato, Celeste Michelle, et al.
Publicado: (2020)

Heterogenetic parabiosis between healthy and dystrophic mice improve the histopathology in muscular dystrophy
por: Lu, Aiping, et al.
Publicado: (2020)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes
por: Haro, Carmen, et al.
Publicado: (2018)

Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress
por: Pichavant, Christophe, et al.
Publicado: (2016)

Hsp40 Gene Therapy Exerts Therapeutic Effects on Polyglutamine Disease Mice via a Non-Cell Autonomous Mechanism
por: Popiel, H. Akiko, et al.
Publicado: (2012)

Home-Based Monitoring of Pulmonary Function in Patients with Duchenne Muscular Dystroph
por: Buyse, Gunnar M., et al.
Publicado: (2018)

Fukutin Protein Participates in Cell Proliferation by Enhancing Cyclin D1 Expression through Binding to the Transcription Factor Activator Protein-1: An In Vitro Study
por: Okamura, Yukinori, et al.
Publicado: (2021)

Characterization of dystroglycan binding in adhesion of human induced pluripotent stem cells to laminin-511 E8 fragment
por: Sugawara, Yumika, et al.
Publicado: (2019)

Progress in muscular dystrophy research with special emphasis on gene therapy
por: SUGITA, Hideo, et al.
Publicado: (2010)

Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs
por: Kuraoka, Mutsuki, et al.
Publicado: (2018)

Prerequisites of Colonoscopy
por: Hong, Kyong Hee, et al.
Publicado: (2014)

Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice
por: Faber, Rachel M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hqmiiiv6tlkj1c62pa5lla8uc5